New Plan Limits Out-of-Pocket Costs for Insulin
WEDNESDAY, April 3, 2019 -- Out-of-pocket costs for insulin could be restricted to $25 a month for people under a drug benefit plan announced Wednesday by Express Scripts.
The average monthly savings for workers whose employers adopt the plan would be about $16 a month, The New York Times reported.
There is rising anger about steep rises in the cost of insulin in recent years. The average price of insulin rose from about $234 a month in 2012 to about $450 a month in 2016, according to the Health Cost Institute. It has become even more costly since 2016, leading some patients without insurance or with high deductibles to ration their doses or even do without the drug, The Times reported.
The cost of insulin has caught the attention of U.S. lawmakers. On Tuesday, patients and doctors testified about rising insulin prices before a subcommittee of the House Energy and Commerce Committee. Next week, the issue is expected to come up when executives from the top pharmacy benefit managers are scheduled to testify before the Senate Finance Committee, The Times reported.
© 2020 HealthDay. All rights reserved.
Posted: April 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.